172 related articles for article (PubMed ID: 27790297)
1. Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres.
Ko JJ; Asif T; Li H; Alimohamed N; Nguyen PT; Heng DY
Can Urol Assoc J; 2016; 10(5-6):E165-E170. PubMed ID: 27790297
[TBL] [Abstract][Full Text] [Related]
2. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
[TBL] [Abstract][Full Text] [Related]
3. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
[TBL] [Abstract][Full Text] [Related]
4. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
5. Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
Bokemeyer C; Hartmann JT; Fossa SD; Droz JP; Schmol HJ; Horwich A; Gerl A; Beyer J; Pont J; Kanz L; Nichols CR; Einhorn L
APMIS; 2003 Jan; 111(1):49-59; discussion 59-63. PubMed ID: 12752235
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements.
Ocal N; Yildiz B; Karadurmus N; Dogan D; Ozaydin S; Ocal R; Ozturk M; Arpaci F; Bilgic H
Onco Targets Ther; 2016; 9():7445-7450. PubMed ID: 28003760
[TBL] [Abstract][Full Text] [Related]
7. Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report.
Tobiume M; Aoki S; Nishikawa G; Muramatsu H; Ono K; Morinaga S; Hara K; Ando N; Ono K; Nishibata C; Hidano A; Nakagawa M; Takahashi I; Matsubara K; Yamada Y
J Med Case Rep; 2021 Feb; 15(1):59. PubMed ID: 33541424
[TBL] [Abstract][Full Text] [Related]
8. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Bokemeyer C; Nichols CR; Droz JP; Schmoll HJ; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Hartmann JT
J Clin Oncol; 2002 Apr; 20(7):1864-73. PubMed ID: 11919246
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
Azrif M; Leong YK; Aslan NM; Fong KV; Ismail F
Asian Pac J Cancer Prev; 2012; 13(6):2467-71. PubMed ID: 22938405
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
[TBL] [Abstract][Full Text] [Related]
11. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.
Makino T; Konaka H; Namiki M
Anticancer Res; 2016 Jan; 36(1):313-7. PubMed ID: 26722059
[TBL] [Abstract][Full Text] [Related]
13. Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.
Hsu YJ; Pai L; Chen YC; Ho CL; Kao WY; Chao TY
Cancer; 2002 Aug; 95(4):766-74. PubMed ID: 12209720
[TBL] [Abstract][Full Text] [Related]
14. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
15. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
Antonelli L; Ardizzone D; Ravi P; Bagrodia A; Mego M; Daneshmand S; Nicolai N; Nazzani S; Giannatempo P; Franza A; Heidenreich A; Paffenholz P; Saoud R; Eggener S; Ho M; Oswald N; Olson K; Tryakin A; Fedyanin M; Naoun N; Javaud C; Fizazi K; King JM; Adra N; Douglawi A; Cary C; Sweeney C; Fankhauser CD
Eur J Cancer; 2023 Mar; 182():144-154. PubMed ID: 36787661
[TBL] [Abstract][Full Text] [Related]
16. Male Extragonadal Germ Cell Tumors of the Adult.
Busch J; Seidel C; Zengerling F
Oncol Res Treat; 2016; 39(3):140-4. PubMed ID: 27032104
[TBL] [Abstract][Full Text] [Related]
17. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
18. Extragonadal germ cell tumors. A 14-year Toronto experience.
Goss PE; Schwertfeger L; Blackstein ME; Iscoe NA; Ginsberg RJ; Simpson WJ; Jones DP; Shepherd FA
Cancer; 1994 Apr; 73(7):1971-9. PubMed ID: 8137224
[TBL] [Abstract][Full Text] [Related]
19. The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients.
Bhala N; Coleman JM; Radstone CR; Horsman JM; George J; Hancock BW; Hatton MQ; Coleman RE
Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):40-7. PubMed ID: 14768754
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]